 NEW YORK, April 12, 2021 PRNewswire -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Luminex Corporation Luminex or the Company NASDAQ: LMNX in connection with the proposed acquisition of the Company by Italian diagnostics group DiaSorin S.p.A. Under the terms of the merger agreement, the Companys shareholders will receive only 37.00 per share in cash for each share of Luminex common stock that they hold. 